Glaukos (GKOS) Shares Outstanding (Diluted Average) (2014 - 2026)
Glaukos (GKOS) reported Shares Outstanding (Diluted Average) of $58.0 million for Q1 2026, up 2.45% year-over-year from $56.6 million in Q1 2025, and up 1.45% on a QoQ basis from $57.2 million in Q4 2025.
Glaukos (GKOS) has 9 years of Shares Outstanding (Diluted Average) data on file, last reported at $58.0 million in Q1 2026.
- Quarterly Shares Outstanding (Diluted Average) rose 2.45% year-over-year to $58.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $58.0 million (up 2.45% YoY) and the FY2025 annual result came in at $57.2 million, up 8.41% from the prior year.
- Shares Outstanding (Diluted Average) advanced to $58.0 million in Q1 2026 per GKOS's latest filing, from $57.2 million in the prior quarter.
- Across five years, Shares Outstanding (Diluted Average) topped out at $58.0 million in Q1 2026 and bottomed at $47.2 million in Q2 2022.
- The 5-year median for Shares Outstanding (Diluted Average) is $49.9 million (2024), against an average of $51.8 million.
- The widest annual swing landed in 2022, when Shares Outstanding (Diluted Average) gained 1.94%; it then increased 14.23% in 2025.
- Tracing GKOS's Shares Outstanding (Diluted Average) over 5 years: stood at $47.4 million in 2022, then gained by 2.08% to $48.4 million in 2023, then climbed by 8.92% to $52.8 million in 2024, then advanced by 8.41% to $57.2 million in 2025, then rose by 1.45% to $58.0 million in 2026.
- Per Business Quant, the three latest GKOS Shares Outstanding (Diluted Average) figures stand at $58.0 million (Q1 2026), $57.2 million (Q4 2025), and $57.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 393.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn | 58.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 58.02 Mn |
| Dec 31, 2025 | 57.19 Mn |
| Sep 30, 2025 | 57.40 Mn |
| Jun 30, 2025 | 56.92 Mn |
| Mar 31, 2025 | 56.64 Mn |
| Dec 31, 2024 | 52.76 Mn |
| Sep 30, 2024 | 55.04 Mn |
| Jun 30, 2024 | 50.17 Mn |
| Mar 31, 2024 | 49.58 Mn |
| Dec 31, 2023 | 48.43 Mn |
| Sep 30, 2023 | 48.68 Mn |
| Jun 30, 2023 | 48.28 Mn |
| Mar 31, 2023 | 47.88 Mn |
| Dec 31, 2022 | 47.44 Mn |
| Sep 30, 2022 | 47.35 Mn |
| Jun 30, 2022 | 47.21 Mn |
| Dec 31, 2021 | 46.42 Mn |
| Sep 30, 2021 | 46.26 Mn |
| Jun 30, 2021 | 46.31 Mn |
| Dec 31, 2016 | 36.46 Mn |
| Dec 31, 2015 | 17.47 Mn |
| Sep 30, 2015 | 32.01 Mn |
| Dec 31, 2014 | 2.29 Mn |
| Sep 30, 2014 | 2.27 Mn |